Boehringer Ingelheim & Taking Cancer On

Cancer

We have a clear aspiration – to transform the lives of people with cancer by delivering meaningful advances, with the ultimate goal of curing a range of cancers. Our generational commitment to driving scientific innovation is reflected by our robust pipeline of cancer cell-directed and immuno-oncology investigational therapies, as well as the smart combination of these approaches. We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research. Simply put, for Boehringer Ingelheim, cancer care is personal, today and for generations.

Latest Article

Illustration of a patient receiving help for a healthcare professional

The power of patient advocacy in cancer care

Learn more about patient Larry and UICC president Jeff Dunn's commitment to patient empowerment.

Brightline-1 trial launch in rare sarcoma

Find out more from Mehdi Lahmar, Clinical Program Leader for Oncology, about our commitment to patients with Dedifferentiated Liposarcoma (DDLPS).

Illustration of two scientists looking at research

Cancer

Transforming Cancer Care

By working with a range of stakeholders, including patients, advocacy organizations, researchers, academics and more, we can make a meaningful impact in transforming the lives of people with cancer.

Cancer

Your Milestones Drive Ours

Learn more about the experiences of living with non-small cell lung cancer and cholangiocarcinoma as well as caring for a loved one during a cancer journey.

Cancer

A unique take on life with an ultra rare cancer

For Dan, being diagnosed with dedifferentiated liposarcoma (DDLPS), an ultra rare cancer, was life changing, and means that he now makes the most of every single day.

Collaborations

Boehringer Ingelheim is involved in long-term collaborations with world leading academics, industry, regulators and payors, as well as patients and advocacy organizations.
We take a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful areas of cancer research.